Here's what you should know about how GLP-1-related weight loss affects your feet, why it happens, and what you can do about it
Here are some tips to make your brew easier on the stomach while still giving you a satisfying caffeine lift
The first GLP-1 agonist was approved for use in Canada in 2017
Retatrutide also covers GLP-1 and GIP (the same receptors tirzepatide hits), so it overlaps
Your bloodstream will carry the glutathione to your brain, lungs, heart, muscle tissue, and all throughout your body to ensure you are fully benefitting from its amazing detoxifying and protective properties

Preventative Services Task Force, Annals of Internal Medicine (2011) XENical in the prevention of diabetes in obese subjects (XENDOS) study: A randomized study of orlistat as an adjunct to lifestyle changes for the prevention of Type 2 diabetes in obese patients, Diabetes Care (2004) Effect of orlistat in overweight and obese patients with Type 2 diabetes treated with metformin, Diabetes Care (2002) Long-term effects of weight-reducing drugs in people with hypertension, The Cochrane Database of Systemic Reviews (2016) The effect of the gastrointestinal lipase inhibitor, orlistat, on serum lipids and lipoproteins in patients with primary hyperlipidaemia, European Journal of Clinical Pharmacology (1994) Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: A randomized trial, JAMA (2005) Switching between glucagon-like peptide-1 receptor agonists: Rationale and practical guidance, Clinical Diabetes (2020) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
